University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Birmingham, UK;Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
J Int Adv Otol. 2021 Jan;17(1):72-80. doi: 10.5152/iao.2020.9226.
This study's aim was to establish outcomes following cochlear implantation (CI) in patients with mitochondrial disorders associated with deafness. Systematic review and narrative synthesis. Databases searched: Medline, EMBASE, Web of Science, COCHRANE, and ClinicalTrials.gov. No limits on language or year of publication. Review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Searches identified 437 abstracts and 37 full text articles, of which 11 studies met the inclusion criteria reporting outcomes in a total of 17 patients. All implants achieved good hearing outcomes, and follow-up ranged between 1 week and 12 months. The methodological quality of the included studies was sufficient, scoring grades 3 to 4 using the Oxford Centre for Evidence Based Medicine grading system. All studies were retrospective and consisted of case reviews and case reports. All cases of CI showed positive outcomes in speech perception and detection. There is some qualitative evidence to suggest improvement in quality of life and satisfaction postoperatively. There was very limited information available on secondary outcomes such as surgical complications, quality of life, and method of cochlear implant insertion. The small sample size of our patient cohort and quality of studies suggests a need for large-scale studies with more robust methodology to assess the effectiveness of CI. There is a need for studies that assess other factors to be considered when counseling patients about cochlear implants, such as adverse events, surgical complications, and long-term benefits.
本研究旨在探讨与耳聋相关的线粒体疾病患者行耳蜗植入(CI)后的结果。系统评价和叙述性综合。检索数据库:Medline、EMBASE、Web of Science、COCHRANE 和 ClinicalTrials.gov。不限制语言或出版年份。审查符合系统评价和荟萃分析报告的首选项目。检索共确定了 437 篇摘要和 37 篇全文文章,其中 11 项研究符合纳入标准,共纳入 17 例患者报告结果。所有植入物均获得良好的听力结果,随访时间为 1 周至 12 个月。纳入研究的方法学质量充足,使用牛津循证医学中心的分级系统评分 3 至 4 级。所有研究均为回顾性,包括病例回顾和病例报告。所有 CI 病例在言语感知和检测方面均显示出积极的结果。有一些定性证据表明术后生活质量和满意度有所提高。关于次要结果,如手术并发症、生活质量和耳蜗植入插入方法,只有非常有限的信息可用。我们患者队列的样本量小和研究质量表明,需要进行更大规模、更稳健方法的研究,以评估 CI 的有效性。需要研究评估其他因素,如不良事件、手术并发症和长期获益,以便为患者提供关于耳蜗植入的咨询。